Celian Jason reported grant involving 25.753 derivative units of Versigent PLC at $0.00 for $0 on Sep 18, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Accounting Officer
Chief Accounting Officer
Filed Sep 22, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
25.753Dividend Equivalent Rights
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
25.753Direct
Trade date
Sep 18, 2026Grant
Filed
Sep 22, 2026, 4:07 PM ET4-day reporting delay
Accession
0001193125-26-397910Code A · Transaction 227444
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

VGNT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VGNT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago −0.4%1d ago +0.9%
Returns since7d −3%30d −7.9%90d180d1y

Footnotes in full

F1: The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.